Hepatology & Liver Transplant Update 2025: Global & India Focus with Dr. Chetan Kalal
Dr. Chetan R. Kalal, DM Hepatology – Maharashtra’s First DM Hepatologist | India’s Leading Liver & Transplant Specialist | Virtual Consults: USA, UAE, Europe, Canada, New Zealand, Australia, Africa, Middle East
🌍 Why This Update Matters
Liver disease is no longer a regional issue—it’s a global health challenge. From fatty liver and cirrhosis to liver cancer and transplants, patients across continents are searching for expert, evidence-based care.
For patients worldwide, this means easier access to leaders like Dr. Chetan Kalal—one of India’s most recognized hepatologists, liver transplant experts, and Maharashtra’s first DM in Hepatology.
🩺 Global Liver Disease Trends 2025
Fatty Liver (MASLD/NASH): Rising rapidly in India, UAE, USA, Canada, and Europe, linked to obesity and diabetes.
Liver Cancer (HCC): Still a major cause of cancer deaths worldwide.
Transplantation Demand: Growing but constrained by donor shortages.
New Hope: Artificial liver devices, stem cell therapies, and FDA-approved drugs like Resmetirom and Tirzepatide.
⚕️ India’s Leadership in Liver Care
India has become a hub for affordable, world-class liver transplants. Mumbai, in particular, is home to advanced transplant programs led by experts like Dr. Kalal.
Dr. Chetan Kalal’s Advantage:
Maharashtra’s first DM Hepatologist
Specializes in complex liver transplants
Pioneer in fatty liver, NASH, and metabolic liver disease
Virtual consults available worldwide
🧬 Future of Liver Transplant & Hepatology
Artificial Livers: Available in select Indian centers (AIIMS, ILBS) as bridge therapy.
Stem Cell Therapy: Showing promise in chronic liver failure, with Indian startups leading trials.
New Drugs:
Resmetirom (Rezdiffra): First FDA-approved drug for NASH.
Tirzepatide: Dual GLP-1/GIP agonist reducing liver fat + improving diabetes.
Regenerative Medicine: Could one day reduce transplant need, though transplant remains the gold standard.
📍 Dr. Chetan Kalal’s Locations (Mumbai & Maharashtra)
Patients across Mumbai and Maharashtra trust Dr. Kalal’s expertise in hepatology and transplantation.
Mumbai: Andheri, Juhu, Bandra, Lokhandwala, Pali Hill, Worli, Lower Parel, Dadar
Maharashtra & Beyond: Virtual consultations extend to all India, Gulf, Africa, Europe, Canada, USA, New Zealand, Australia
💻 Virtual Consultations – Global Access
Dr. Kalal provides virtual second opinions and consultations for patients in:
USA & Canada – NASH, fatty liver, transplant evaluations
UAE, Middle East & Africa – cirrhosis and viral hepatitis management
Europe, Australia, New Zealand – global hepatology care, bridging patients to Indian transplant centers
🌐 Patients outside India can consult virtually before traveling for transplant or advanced liver care.
❓ Frequently Asked Questions (FAQ)
1. Is liver transplant safe in India?
Yes. India offers world-class transplant outcomes at significantly lower costs than the US or Europe, led by experts like Dr. Kalal.
2. Are artificial livers available in Mumbai?
They are available only in specialized centers and trials as bridge therapies, not yet mainstream.
3. Can fatty liver be treated without transplant?
Yes—lifestyle changes, medications like Resmetirom/Tirzepatide, and early intervention can reverse fatty liver in many cases.
4. How do I book a virtual consultation with Dr. Chetan Kalal?
Patients can book online consultations from USA, UAE, Canada, Europe, New Zealand, Australia, Africa, and across India for expert hepatology and transplant advice.
📢 Conclusion
The future of liver care is global, digital, and innovation-driven. Artificial livers, stem cells, and breakthrough drugs are reshaping treatment, but transplant remains life-saving for end-stage disease.
Whether you are in Mumbai, Dubai, London, Toronto, Sydney, or Nairobi, Dr. Chetan Kalal brings world-class hepatology expertise and transplant leadership directly to you.
👉 For appointments: drchetankalal.com
